ArriVent Biopharma, Inc. Collaboration Agreements
3 Contracts & Agreements
- Clinical Collaboration Agreement, by and between the Registrant and Beijing InnoCare Pharma Tech Co., Ltd., dated June 23, 2023 (Filed With SEC on January 5, 2024)
- Research Collaboration Agreement, dated December 21, 2021, by and between Aarvik Therapeutics, Inc. and the Registrant, as amended by Amendment No. 1, effective June 30, 2023 (Filed With SEC on January 5, 2024)
- Joint Clinical Collaboration Agreement, by and between the Registrant and Shanghai Allist Pharmaceuticals Co., Ltd., dated December 24, 2021 (Filed With SEC on January 5, 2024)